Udtohan, Juvelie .
HRN: 19-26-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFUROXIME 750MG (VIAL)
10/25/2023
11/01/2023
IV
750mg
Q8h
T/c Pyelonephritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes